General Information of Drug (ID: DM105TB)

Drug Name
SAR444881 Drug Info
Indication
Disease Entry ICD 11 Status REF
Aggressive cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM105TB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NGM707 DMA5DDI Aggressive cancer 2A00-2F9Z Phase 2 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1) TTC0QRJ LIRB1_HUMAN Not Available [1]

References

1 Clinical pipeline report, company report or official report of Sanofi
2 Clinical pipeline report, company report or official report of NGM Biopharma